Annual Gross Profit
$7.89 M
+$114.00 K+1.47%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual gross profit is $7.89 million, with the most recent change of +$114.00 thousand (+1.47%) on December 1, 2023.
- During the last 3 years, NBY annual gross profit has risen by +$1.93 million (+32.38%).
- NBY annual gross profit is now -49.66% below its all-time high of $15.68 million, reached on December 31, 2009.
Performance
NBY Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$1.59 M
+$1000.00+0.06%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly gross profit is $1.59 million, with the most recent change of +$1000.00 (+0.06%) on September 1, 2024.
- Over the past year, NBY quarterly gross profit has dropped by -$69.00 thousand (-4.15%).
- NBY quarterly gross profit is now -78.74% below its all-time high of $7.49 million, reached on December 31, 2009.
Performance
NBY Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$7.87 M
-$69.00 K-0.87%
September 1, 2024
Summary
- As of February 7, 2025, NBY TTM gross profit is $7.87 million, with the most recent change of -$69.00 thousand (-0.87%) on September 1, 2024.
- Over the past year, NBY TTM gross profit has increased by +$1.12 million (+16.53%).
- NBY TTM gross profit is now -49.80% below its all-time high of $15.68 million, reached on December 31, 2009.
Performance
NBY TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
NBY Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.5% | -4.2% | +16.5% |
| 3 y3 years | +32.4% | -8.4% | +5.4% |
| 5 y5 years | -28.3% | -8.4% | +5.4% |
NBY Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +21.2% | -45.0% | +0.1% | -2.7% | +29.0% |
| 5 y | 5-year | at high | +62.4% | -45.0% | +48.2% | -2.7% | +62.0% |
| alltime | all time | -49.7% | -100.0% | -78.7% | +1417.1% | -49.8% | +1288.5% |
NovaBay Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.59 M(+0.1%) | $7.87 M(-0.9%) |
| Jun 2024 | - | $1.59 M(-11.3%) | $7.94 M(-1.8%) |
| Mar 2024 | - | $1.79 M(-38.0%) | $8.09 M(+2.5%) |
| Dec 2023 | $7.89 M(+1.5%) | $2.89 M(+74.1%) | $7.89 M(+16.9%) |
| Sep 2023 | - | $1.66 M(-4.4%) | $6.76 M(-9.5%) |
| Jun 2023 | - | $1.74 M(+8.7%) | $7.47 M(-1.3%) |
| Mar 2023 | - | $1.60 M(-8.8%) | $7.57 M(-2.7%) |
| Dec 2022 | $7.78 M(+19.4%) | $1.75 M(-26.1%) | $7.78 M(+1.0%) |
| Sep 2022 | - | $2.38 M(+29.2%) | $7.71 M(+11.9%) |
| Jun 2022 | - | $1.84 M(+1.3%) | $6.88 M(+4.9%) |
| Mar 2022 | - | $1.81 M(+8.1%) | $6.56 M(+7.6%) |
| Dec 2021 | $6.51 M(+9.2%) | $1.68 M(+8.0%) | $6.10 M(+11.0%) |
| Sep 2021 | - | $1.55 M(+2.2%) | $5.50 M(-1.5%) |
| Jun 2021 | - | $1.52 M(+12.4%) | $5.58 M(-7.1%) |
| Mar 2021 | - | $1.35 M(+25.8%) | $6.00 M(+0.7%) |
| Dec 2020 | $5.96 M(+22.7%) | $1.07 M(-34.2%) | $5.96 M(-0.6%) |
| Sep 2020 | - | $1.63 M(-15.9%) | $6.00 M(+7.5%) |
| Jun 2020 | - | $1.94 M(+48.3%) | $5.58 M(+11.1%) |
| Mar 2020 | - | $1.31 M(+18.0%) | $5.02 M(+3.3%) |
| Dec 2019 | $4.86 M(-55.8%) | $1.11 M(-8.5%) | $4.86 M(-29.9%) |
| Sep 2019 | - | $1.21 M(-12.4%) | $6.93 M(-18.7%) |
| Jun 2019 | - | $1.39 M(+20.5%) | $8.53 M(-9.8%) |
| Mar 2019 | - | $1.15 M(-63.9%) | $9.46 M(-14.0%) |
| Dec 2018 | $11.01 M(-28.8%) | $3.18 M(+13.3%) | $11.01 M(-16.4%) |
| Sep 2018 | - | $2.81 M(+21.4%) | $13.16 M(-5.5%) |
| Jun 2018 | - | $2.31 M(-14.1%) | $13.92 M(-7.4%) |
| Mar 2018 | - | $2.70 M(-49.5%) | $15.03 M(-2.7%) |
| Dec 2017 | $15.45 M(+63.7%) | $5.34 M(+49.6%) | $15.45 M(+15.5%) |
| Sep 2017 | - | $3.57 M(+4.3%) | $13.38 M(+5.5%) |
| Jun 2017 | - | $3.42 M(+10.0%) | $12.68 M(+10.8%) |
| Mar 2017 | - | $3.11 M(-4.8%) | $11.44 M(+21.3%) |
| Dec 2016 | $9.43 M | $3.27 M(+13.8%) | $9.43 M(+30.9%) |
| Sep 2016 | - | $2.87 M(+31.5%) | $7.21 M(+36.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $2.18 M(+97.1%) | $5.27 M(+37.2%) |
| Mar 2016 | - | $1.11 M(+6.1%) | $3.84 M(+23.0%) |
| Dec 2015 | $3.12 M(+449.3%) | $1.04 M(+12.1%) | $3.12 M(+37.4%) |
| Sep 2015 | - | $931.00 K(+23.3%) | $2.27 M(+56.7%) |
| Jun 2015 | - | $755.00 K(+93.6%) | $1.45 M(+81.4%) |
| Mar 2015 | - | $390.00 K(+101.0%) | $799.00 K(+40.9%) |
| Dec 2014 | $568.00 K(-82.9%) | $194.00 K(+76.4%) | $567.00 K(-29.4%) |
| Sep 2014 | - | $110.00 K(+4.8%) | $803.00 K(-54.1%) |
| Jun 2014 | - | $105.00 K(-33.5%) | $1.75 M(-29.4%) |
| Mar 2014 | - | $158.00 K(-63.3%) | $2.48 M(-25.3%) |
| Dec 2013 | $3.31 M(-52.2%) | $430.00 K(-59.3%) | $3.32 M(-16.9%) |
| Sep 2013 | - | $1.06 M(+26.9%) | $3.99 M(-39.3%) |
| Jun 2013 | - | $832.00 K(-16.6%) | $6.58 M(-0.6%) |
| Mar 2013 | - | $998.00 K(-9.7%) | $6.62 M(-4.6%) |
| Dec 2012 | $6.94 M(-37.0%) | $1.10 M(-69.7%) | $6.94 M(-1.8%) |
| Sep 2012 | - | $3.64 M(+318.1%) | $7.06 M(+14.0%) |
| Jun 2012 | - | $871.00 K(-34.0%) | $6.19 M(-37.1%) |
| Mar 2012 | - | $1.32 M(+7.3%) | $9.85 M(-10.6%) |
| Dec 2011 | $11.02 M(-29.7%) | $1.23 M(-55.6%) | $11.02 M(+12.6%) |
| Sep 2011 | - | $2.77 M(-38.8%) | $9.79 M(+7.5%) |
| Jun 2011 | - | $4.53 M(+81.8%) | $9.10 M(+27.8%) |
| Mar 2011 | - | $2.49 M(+19.4%) | $7.12 M(-49.9%) |
| Sep 2010 | - | $2.09 M(-18.1%) | $14.21 M(-7.4%) |
| Jun 2010 | - | $2.55 M(+22.3%) | $15.35 M(+1.3%) |
| Mar 2010 | - | $2.08 M(-72.2%) | $15.16 M(-3.4%) |
| Dec 2009 | $15.68 M(+133.3%) | $7.49 M(+132.4%) | $15.68 M(+51.0%) |
| Sep 2009 | - | $3.22 M(+36.8%) | $10.39 M(+18.6%) |
| Jun 2009 | - | $2.36 M(-9.7%) | $8.76 M(+11.7%) |
| Mar 2009 | - | $2.61 M(+18.9%) | $7.84 M(+16.6%) |
| Dec 2008 | $6.72 M(>+9900.0%) | $2.20 M(+37.9%) | $6.72 M(+48.5%) |
| Sep 2008 | - | $1.59 M(+10.4%) | $4.53 M(+54.3%) |
| Jun 2008 | - | $1.44 M(-3.4%) | $2.93 M(+96.6%) |
| Mar 2008 | - | $1.49 M | $1.49 M |
| Dec 2003 | $0.00 | - | - |
FAQ
- What is NovaBay Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual gross profit year-on-year change?
- What is NovaBay Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly gross profit year-on-year change?
- What is NovaBay Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals TTM gross profit year-on-year change?
What is NovaBay Pharmaceuticals annual gross profit?
The current annual gross profit of NBY is $7.89 M
What is the all time high annual gross profit for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual gross profit is $15.68 M
What is NovaBay Pharmaceuticals annual gross profit year-on-year change?
Over the past year, NBY annual gross profit has changed by +$114.00 K (+1.47%)
What is NovaBay Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of NBY is $1.59 M
What is the all time high quarterly gross profit for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly gross profit is $7.49 M
What is NovaBay Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, NBY quarterly gross profit has changed by -$69.00 K (-4.15%)
What is NovaBay Pharmaceuticals TTM gross profit?
The current TTM gross profit of NBY is $7.87 M
What is the all time high TTM gross profit for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high TTM gross profit is $15.68 M
What is NovaBay Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, NBY TTM gross profit has changed by +$1.12 M (+16.53%)